We investigated the antinociceptive effect of microinjection of HSV-1 amplicon vector-mediated human proenkephalin (hPPE) into the ventral periaqueductal grey (PAG) on neuropathic pain in rats. Male Sprague-Dawley rats with chronic constriction injury (CCI)-induced neuropathic pain were microinjected into the ventral PAG with normal saline (NS), pHSVIRES-lacZ (SHZ), or HSV-1 amplicon vector pHSVIRES-hPPE-lacZ (SHPZ), respectively. Pain thresholds in the SHPZ-treated rats were significantly higher at day 3, then reached peak at day 14 and lasted until day 35 after PAG administration, and these effects were reversed by naloxone. In contrast, NS or SHZ-treated rats did not significantly affect pain thresholds. These results demonstrated that microinjection of HSV-1 amplicon vector-mediated hPPE into the ventral PAG attenuates neuropathic pain in rats.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/00207454.2011.637653 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Co-infection of HSV-1 amplicons containing the gene and a human artificial chromosome vector into primary XPC deficient fibroblast cells.
Biochem Biophys Rep
December 2024
Tufts University, Department of Biomedical Engineering, 4 Colby Street, Medford, 02155, USA.
Article Synopsis
Non-replicative herpes simplex virus genomic and amplicon vectors for gene therapy - an update.
Gene Ther
November 2024
EG 427 SAS, Paris, France.
Two major types of defective vectors have been derived from herpes simplex virus type 1 (HSV-1), non-replicative genomic vectors (nrHSV-1), and amplicon vectors. This review recapitulates the main features of both vector types and summarizes recent improvements in our understanding of virus/vector biology, particularly with regard to the critical role played by the overpowering of antiviral cellular defenses and the epigenetic control of viral gene expression. Over the past years, significant breakthroughs in vector design, genetic engineering, and HSV-1 biology have accelerated the development of nrHSV-1 vectors.
View Article and Find Full Text PDFSequence analysis of isolated strains of herpes zoster virus among patients with shingles.
Iran J Microbiol
August 2024
Department of Dermatology, College of Medicine, University of Thi-Qar, Thi-Qar, Iraq.
Article Synopsis
- Herpes zoster (shingles) is caused by the varicella-zoster virus (VZV), affecting about 10-20% of adults over 50 and posing a 30% risk for the general population, especially during winter and spring.
- The study analyzed 50 cases of herpes zoster from October 2020 to April 2021, using PCR to detect VZV in skin lesions by amplifying specific genes (gpB and MCP) and sequencing the results.
- Results showed high similarity to known VZV sequences, identifying six genetic variants and eight single-nucleotide polymorphisms (SNPs) that caused changes in the gpB protein, with the findings recorded in NCB
Letermovir use may impact on the Cytomegalovirus DNA fragmentation profile in plasma from allogeneic hematopoietic stem cell transplant recipients.
J Med Virol
March 2024
Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Cytomegalovirus (CMV) DNA in plasma is mainly unprotected and highly fragmented. The size of the amplicon largely explains the variation in CMV DNA loads quantified across PCR platforms. In this proof-of-concept study, we assessed whether the CMV DNA fragmentation profile may vary across allogeneic hematopoietic stem cell transplant recipients (allo-SCT), within the same patient over time, or is affected by letermovir (LMV) use.
View Article and Find Full Text PDFAssessment of Residual Full-Length SV40 Large T Antigen in Clinical-Grade Adeno-Associated Virus Vectors Produced in 293T Cells.
Hum Gene Ther
August 2023
Department of Genetic Medicine, Weill Cornell Medicine, New York, New York, USA.
Efficient production of adeno-associated virus (AAV) vectors is a significant challenge. Human embryonic kidney HEK293T cells are widely used in good manufacturing practice facilities, producing higher yield of AAV vectors for clinical applications than HEK293 through the addition of a constitutive expression of SV40 large T antigen (SV40T), which stimulates Rep expression. However, the theoretical potential for tumorigenic consequences of a clinical AAV product containing residual DNA encoding SV40T, which may inhibit p53 growth suppressive functions is a safety concern.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!